Intravascular thrombus adhering to an underlying atherosclerotic plaque impairs flow dynamics and represents a considerable obstacle for the safety and effectiveness of revascularization.

--(BUSINESS WIRE)--Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems ... of existing and forthcoming intravascular neuro devices.

Seasoned Medtech Executive to Expand Company Presence Into U.S. Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke ...